Company Filing History:
Years Active: 2015-2022
Title: The Innovations of Soyoun Kim: Pioneering Advances in Thrombotic Disorder Treatments
Introduction
Soyoun Kim, based in Daegu, South Korea, is an accomplished inventor with a notable portfolio of three patents. His work primarily focuses on the development of novel therapeutic approaches targeting thrombotic disorders, showcasing a blend of innovative peptides aimed at enhancing treatment efficacy and safety.
Latest Patents
One of Soyoun Kim's significant inventions is a fusion peptide that incorporates a thrombus-targeting peptide, ferritin fragment, and thrombolytic peptide. This invention describes a therapeutic agent that not only selectively targets thrombus sites but also exhibits a low sensitivity to inhibitors typically found in the circulatory system. Additionally, this fusion peptide demonstrates impressive pharmacological activity, effectively breaking down both arterial and venous thrombi without causing bleeding side effects. Such characteristics make it a promising candidate for developing advanced treatments for thrombotic disorders.
Another remarkable innovation by Kim is a human ferritin-derived fusion polypeptide. This polypeptide includes a first fragment fused within specific amino acid positions of a human-derived ferritin monomer, highlighting the intricate design of protein-based therapeutics that Kim is committed to advancing.
Career Highlights
Soyoun Kim is associated with the Kyungpook National University Industry-Academic Cooperation Foundation, where he contributes to pioneering research and innovation in medical treatments. His work aims to bridge the gap between academic research and practical therapeutic applications, ensuring that scientific advancements translate into effective treatments.
Collaborations
Throughout his career, Soyoun has collaborated with notable peers, including In-Seop So and In San Kim. These collaborations amplify the innovative potential of his research, fostering a dynamic environment for developing groundbreaking therapeutic strategies.
Conclusion
Soyoun Kim stands at the forefront of innovation in the field of thrombotic disorder treatment. His patents reflect a commitment to enhancing patient care through the development of targeted, effective, and safe therapeutic agents. As he continues to collaborate and innovate, Kim's contributions are poised to make significant impacts in medical science and improve treatment outcomes for patients affected by thrombotic disorders.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.